Literature DB >> 22783401

Nuclear Aurora B and cytoplasmic Survivin expression is involved in lymph node metastasis of colorectal cancer.

Handan Tuncel1, Fumio Shimamoto, Hiroshi Kaneko Guangying Qi, Eriko Aoki, Hiroshi Jikihara, Shiro Nakai, Takashi Takata, Masaaki Tatsuka.   

Abstract

The chromosomal passenger complex (CPC) is a key regulator of chromosome segregation and cytokinesis, and consists of Aurora B kinase, INCENP, Survivin and Borealin. Aurora B is a member of a family of serine/threonine protein kinases, and Survivin belongs to the inhibitors of apoptosis (IAP) gene family, and is also a member of the CPC family. Aurora B and Survivin have also been reported to be overexpressed in various human cancers; however, as yet no studies have investigated the co-expression of Survivin and Aurora B in colorectal carcinoma. Therefore, in the present study, the correlation between Aurora B and Survivin expression was investigated using immunohistochemistry and the associated pathological features in colorectal carcinoma were analyzed. Our present findings showed that nuclear Aurora B and cytoplasmic Survivin expression are strongly associated with and involved in lymph node metastasis in colorectal cancer. Therefore, we suggest that nuclear Aurora B and cytoplasmic Survivin are useful diagnostic markers and therapeutic targets in colorectal carcinoma.

Entities:  

Year:  2012        PMID: 22783401      PMCID: PMC3389699          DOI: 10.3892/ol.2012.633

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  22 in total

1.  Aurora-B/AIM-1 kinase activity is involved in Ras-mediated cell transformation.

Authors:  Akifumi Kanda; Hidehiko Kawai; Shiho Suto; Shojiro Kitajima; Sunao Sato; Takashi Takata; Masaaki Tatsuka
Journal:  Oncogene       Date:  2005-11-10       Impact factor: 9.867

Review 2.  Survivin - an anti-apoptosis protein: its biological roles and implications for cancer and beyond.

Authors:  Shiun-Kwei Chiou; Michael K Jones; Andrzej S Tarnawski
Journal:  Med Sci Monit       Date:  2003-04

3.  Mitotic phosphorylation of histone H3 is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes.

Authors:  J Y Hsu; Z W Sun; X Li; M Reuben; K Tatchell; D K Bishop; J M Grushcow; C J Brame; J A Caldwell; D F Hunt; R Lin; M M Smith; C D Allis
Journal:  Cell       Date:  2000-08-04       Impact factor: 41.582

4.  Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma.

Authors:  Masahide Ikeguchi; Tsuyoshi Ueta; Yoshiaki Yamane; Yasuaki Hirooka; Nobuaki Kaibara
Journal:  Clin Cancer Res       Date:  2002-10       Impact factor: 12.531

5.  Prognostic significance of survivin expression in diffuse large B-cell lymphomas.

Authors:  C Adida; C Haioun; P Gaulard; E Lepage; P Morel; J Briere; H Dombret; F Reyes; J Diebold; C Gisselbrecht; G Salles; D C Altieri; T J Molina
Journal:  Blood       Date:  2000-09-01       Impact factor: 22.113

6.  The Survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function.

Authors:  Shirley K Knauer; Carolin Bier; Negusse Habtemichael; Roland H Stauber
Journal:  EMBO Rep       Date:  2006-11-10       Impact factor: 8.807

7.  Multinuclearity and increased ploidy caused by overexpression of the aurora- and Ipl1-like midbody-associated protein mitotic kinase in human cancer cells.

Authors:  M Tatsuka; H Katayama; T Ota; T Tanaka; S Odashima; F Suzuki; Y Terada
Journal:  Cancer Res       Date:  1998-11-01       Impact factor: 12.701

8.  Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis.

Authors:  Reiko Honda; Roman Körner; Erich A Nigg
Journal:  Mol Biol Cell       Date:  2003-05-29       Impact factor: 4.138

9.  Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation.

Authors:  Rosanna Sorrentino; Silvana Libertini; Pier Lorenzo Pallante; Giancarlo Troncone; Lucio Palombini; Vassilios Bavetsias; Daniela Spalletti-Cernia; Paolo Laccetti; Spiros Linardopoulos; Paolo Chieffi; Alfredo Fusco; Giuseppe Portella
Journal:  J Clin Endocrinol Metab       Date:  2004-11-23       Impact factor: 5.958

10.  Targeting Aurora kinases for the treatment of prostate cancer.

Authors:  Edmund Chun Yu Lee; Anna Frolov; Rile Li; Gustavo Ayala; Norman M Greenberg
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

View more
  16 in total

1.  Aurora B expression and histone variant H1.4S27 phosphorylation are no longer coordinated during metaphase in aneuploid colorectal carcinomas.

Authors:  Fahima Sijare; Anna-Lena Geißler; Christiane D Fichter; Sonja P Hergeth; Lioudmila Bogatyreva; Dieter Hauschke; Robert Schneider; Martin Werner; Silke Lassmann
Journal:  Virchows Arch       Date:  2015-02-14       Impact factor: 4.064

2.  Knockdown of Aurora-B inhibits osteosarcoma cell invasion and migration via modulating PI3K/Akt/NF-κB signaling pathway.

Authors:  Liang Bo Zhu; Jian Jiang; Xiao Ping Zhu; Tao Fang Wang; Xuan Yin Chen; Qin Feng Luo; Yong Shu; Zhi Li Liu; Shan Hu Huang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

3.  Expression of survivin, MUC2 and MUC5 in colorectal cancer and their association with clinicopathological characteristics.

Authors:  Haipeng Wang; Shengjian Jin; Huiling Lu; Sisi Mi; Wenhua Shao; Xiaoxv Zuo; Huangyi Yin; Sien Zeng; Fumio Shimamoto; Guangying Qi
Journal:  Oncol Lett       Date:  2017-05-19       Impact factor: 2.967

4.  Structural Characterization of the Aurora Kinase B "DFG-flip" Using Metadynamics.

Authors:  Naga Rajiv Lakkaniga; Meenakshisundaram Balasubramaniam; Shuxing Zhang; Brendan Frett; Hong-Yu Li
Journal:  AAPS J       Date:  2019-12-18       Impact factor: 4.009

5.  Let-7g reverses malignant phenotype of osteosarcoma cells by targeting Aurora-B.

Authors:  Jia Ming Liu; Xin Hua Long; Guo Mei Zhang; Yang Zhou; Xuan Yin Chen; Shan Hu Huang; Zhi Li Liu; Zhi Hong Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

6.  RNA interference-mediated knockdown of Aurora-B alters the metastatic behavior of A549 cells via modulation of the phosphoinositide 3-kinase/Akt signaling pathway.

Authors:  Long Dian Zhou; Xu Xiong; Xin Hua Long; Zhi Li Liu; Shan Hu Huang; Wei Zhang
Journal:  Oncol Lett       Date:  2014-08-20       Impact factor: 2.967

7.  Inhibition of Aurora-B suppresses HepG2 cell invasion and migration via the PI3K/Akt/NF-κB signaling pathway in vitro.

Authors:  Ren Feng Shan; Yun Fei Zhou; Ai Fen Peng; Zhi Gang Jie
Journal:  Exp Ther Med       Date:  2014-07-14       Impact factor: 2.447

8.  Inhibition of Aurora-B suppresses osteosarcoma cell migration and invasion.

Authors:  Xiao Ping Zhu; Zhi Li Liu; Ai Fen Peng; Yun Fei Zhou; Xin Hua Long; Qing Feng Luo; Shan Hu Huang; Yong Shu
Journal:  Exp Ther Med       Date:  2014-01-20       Impact factor: 2.447

9.  Inhibition of Aurora B by CCT137690 sensitizes colorectal cells to radiotherapy.

Authors:  Xiaoyu Wu; Wentao Liu; Qinhong Cao; Che Chen; Zhiwei Chen; Zhe Xu; Weisu Li; Fukun Liu; Xuequan Yao
Journal:  J Exp Clin Cancer Res       Date:  2014-01-29

10.  PARP6 acts as a tumor suppressor via downregulating Survivin expression in colorectal cancer.

Authors:  Guangying Qi; Yasusei Kudo; Bo Tang; Tian Liu; Shengjian Jin; Jing Liu; Xiaoxu Zuo; Sisi Mi; Wenhuan Shao; Xiaojuan Ma; Takaaki Tsunematsu; Naozumi Ishimaru; Sien Zeng; Masaaki Tatsuka; Fumio Shimamoto
Journal:  Oncotarget       Date:  2016-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.